Stock Events

Stock Events

Clearmind Medicine 

€25.48
46
-€2.24-8.08% Friday 15:49

Statistics

Day High
0.06
Day Low
0.06
52W High
1.46
52W Low
0.06
Volume
10,000
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.86MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CWY0.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.59B
COMPASS Pathways is focused on psilocybin therapy for mental health conditions, competing in the psychedelic medicine sector alongside Clearmind Medicine.
AtaiBeckley
ATAI
Mkt Cap1.59B
ATAI Life Sciences is a biotech company developing treatments for mental health disorders, including psychedelic and non-psychedelic compounds, making it a competitor in the broader mental health treatment market.
GH Research
GHRS
Mkt Cap1.52B
GH Research is developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment market for mental health, similar to Clearmind's objectives.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is engaged in the development of psychedelic therapies and wellness services, competing in the same sector as Clearmind Medicine.
MiniMed Group
MMED
Mkt Cap3.1B
MindMedicine (MindMed) Inc. is another key player in the psychedelic medicine space, focusing on developing treatments for mental illness and addiction, directly competing with Clearmind Medicine.
Revive Therapeutics
RVVTF
Mkt Cap9.58M
Revive Therapeutics is exploring the use of psychedelics in treatments, including psilocybin for substance abuse, positioning it as a competitor in the psychedelic therapy market.

About

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
Show more...
CEO
Dr. Adi Zuloff-Shani Ph.D.
Employees
4
Country
United States
ISIN
CA1850536006
WKN
000A427B1

Listings

F
DE
CWY0.F
XNAS
US
CMND
MU
DE
CWY0.MU
STU
DE
CWY0.STU

0 Comments

Share your thoughts

FAQ

What is Clearmind Medicine stock price today?▼
The current price of CWY0.F is €25.48 EUR — it has decreased by -8.08% in the past 24 hours. Watch Clearmind Medicine stock price performance more closely on the chart.
What is Clearmind Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Clearmind Medicine stocks are traded under the ticker CWY0.F.
Is Clearmind Medicine stock price growing?▼
CWY0.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Clearmind Medicine has showed a -92.18% decrease.
What is Clearmind Medicine revenue for the last year?▼
Clearmind Medicine revenue for the last year amounts to 0 EUR.
What is Clearmind Medicine net income for the last year?▼
CWY0.F net income for the last year is -4.86M EUR.
How many employees does Clearmind Medicine have?▼
As of May 26, 2026, the company has 4 employees.
In which sector is Clearmind Medicine located?▼
Clearmind Medicine operates in the Health & Wellness sector.
When did Clearmind Medicine complete a stock split?▼
The last stock split for Clearmind Medicine was on May 21, 2026 with a ratio of 1:10.
Where is Clearmind Medicine headquartered?▼
Clearmind Medicine is headquartered in Vancouver, United States.